Free Trial
NASDAQ:COO

Cooper Companies (COO) Stock Price, News & Analysis

Cooper Companies logo
$83.70 -0.37 (-0.44%)
Closing price 03/25/2025 04:00 PM Eastern
Extended Trading
$83.50 -0.20 (-0.24%)
As of 03/25/2025 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Cooper Companies Stock (NASDAQ:COO)

Key Stats

Today's Range
$83.07
$84.58
50-Day Range
$77.73
$99.35
52-Week Range
$77.05
$112.38
Volume
1.67 million shs
Average Volume
1.29 million shs
Market Capitalization
$16.74 billion
P/E Ratio
42.92
Dividend Yield
N/A
Price Target
$110.25
Consensus Rating
Moderate Buy

Company Overview

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific. The CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage to health care professionals and patients worldwide. It offers surgical and office products, including endosee endometrial imaging products, fetal pillow cephalic elevation devices for use in cesarean sections, illuminated speculum products, lone star retractor systems, loop electrosurgical excision procedure products, mara water ablation systems, paragard contraceptive IUDs, point-of-care, and uterine positioning products, as well as cryostorage, such as cord blood and cord tissue storage; fertility products and services, such as fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.

Remove Ads

Cooper Companies Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
67th Percentile Overall Score

COO MarketRank™: 

Cooper Companies scored higher than 67% of companies evaluated by MarketBeat, and ranked 322nd out of 940 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Cooper Companies has received a consensus rating of Moderate Buy. The company's average rating score is 2.70, and is based on 7 buy ratings, 3 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Cooper Companies has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Cooper Companies' stock forecast and price target.
  • Earnings Growth

    Earnings for Cooper Companies are expected to grow by 11.81% in the coming year, from $3.98 to $4.45 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Cooper Companies is 42.92, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 22.85.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Cooper Companies is 42.92, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 24.55.

  • Price to Earnings Growth Ratio

    Cooper Companies has a PEG Ratio of 2.25. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Cooper Companies has a P/B Ratio of 2.07. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Cooper Companies' valuation and earnings.
  • Percentage of Shares Shorted

    1.57% of the float of Cooper Companies has been sold short.
  • Short Interest Ratio / Days to Cover

    Cooper Companies has a short interest ratio ("days to cover") of 1.8, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Cooper Companies has recently increased by 2.67%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Cooper Companies does not currently pay a dividend.

  • Dividend Growth

    Cooper Companies does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    1.57% of the float of Cooper Companies has been sold short.
  • Short Interest Ratio / Days to Cover

    Cooper Companies has a short interest ratio ("days to cover") of 1.8, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Cooper Companies has recently increased by 2.67%, indicating that investor sentiment is decreasing.
  • News Sentiment

    Cooper Companies has a news sentiment score of 1.35. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.77 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 23 news articles for Cooper Companies this week, compared to 14 articles on an average week.
  • Search Interest

    Only 2 people have searched for COO on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • MarketBeat Follows

    Only 3 people have added Cooper Companies to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Cooper Companies insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 1.98% of the stock of Cooper Companies is held by insiders.

  • Percentage Held by Institutions

    Only 24.39% of the stock of Cooper Companies is held by institutions.

  • Read more about Cooper Companies' insider trading history.
Receive COO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cooper Companies and its competitors with MarketBeat's FREE daily newsletter.

COO Stock News Headlines

In this photo provided by the Serbian Interior Ministry, Serbian Gendarmerie officers show the U
'Like a sound from hell:' Was an illegal sonic weapon used against peaceful protesters in Serbia?
Serbia's populist government is facing increased public scrutiny over reports that it used a sonic weapon against a peaceful crowd during a massive anti-corruption rally in the capital, Belgrade, on March 15
Canada's Vasek Pospisil and Serbia's Novak Djokovic talk tactics during their double match against …
A players' group founded by Novak Djokovic files an antitrust suit against tennis' organizers
The players’ association co-founded by 24-time Grand Slam champion Novak Djokovic has filed an antitrust lawsuit against the women’s and men’s professional tours, the International Tennis Federation and the sport’s integrity agency
AI Boom Takes a Shocking Turn…
AI is Creating Fortunes… (but not where you think!) Bryce Paul and the team at Crypto101 just released a brand-new report…
State Sen
North Carolina Republicans seek to force top Democrats to fall in line with Trump agenda
North Carolina Republicans who are resolved to promote President Donald Trump’s agenda want to compel the new Democratic governor to aid the president's immigration policy
Panama's President Jose Mulino waves as he arrives to Congress to attend President-elect Yamandu Or…
Panama president calls Trump's talk of 'reclaiming' the Panama Canal a lie
Panama President José Raúl Mulino has accused U.S. President Donald Trump of lying when Trump said in his address to Congress the night before that his administration was “reclaiming” the Panama Canal
See More Headlines

COO Stock Analysis - Frequently Asked Questions

Cooper Companies' stock was trading at $91.93 at the beginning of the year. Since then, COO stock has decreased by 9.0% and is now trading at $83.70.
View the best growth stocks for 2025 here
.

The Cooper Companies, Inc. (NASDAQ:COO) issued its quarterly earnings data on Thursday, March, 6th. The medical device company reported $0.92 earnings per share for the quarter, hitting analysts' consensus estimates of $0.92. The medical device company had revenue of $964.70 million for the quarter, compared to the consensus estimate of $981.25 million. Cooper Companies had a trailing twelve-month return on equity of 9.38% and a net margin of 10.07%.

Shares of Cooper Companies split on Tuesday, February 20th 2024. The 4-1 split was announced on Tuesday, February 20th 2024. The newly issued shares were payable to shareholders after the market closes on Tuesday, February 20th 2024. An investor that had 100 shares of stock prior to the split would have 400 shares after the split.

The following companies are subsidiaries of Cooper Companies: Cooper Medical Inc., CooperSurgical, CooperSurgical Holdings Ltd., Coopervision, CooperVision Australia Pty Limited, CooperVision Canada Corp., CooperVision Caribbean Corp, and more.

Cooper Companies' top institutional investors include Vanguard Group Inc. (11.95%), Kayne Anderson Rudnick Investment Management LLC (4.05%), T. Rowe Price Investment Management Inc. (3.85%) and JPMorgan Chase & Co. (2.51%). Insiders that own company stock include Robert S Weiss, Albert G White III, Jody S Lindell, Daniel G Mcbride, Brian G Andrews, Gary S Petersmeyer, Gerard H Warner III and Agostino Ricupati.
View institutional ownership trends
.

Shares of COO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Cooper Companies investors own include NVIDIA (NVDA), Meta Platforms (META), Netflix (NFLX), Advanced Micro Devices (AMD), Tesla (TSLA), JPMorgan Chase & Co. (JPM) and Visa (V).

Company Calendar

Last Earnings
3/06/2025
Today
3/26/2025
Next Earnings (Estimated)
5/29/2025
Fiscal Year End
10/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Ophthalmic goods
Sub-Industry
Health Care Supplies
Current Symbol
NASDAQ:COO
Previous Symbol
NYSE:COO
Employees
16,000
Year Founded
1958

Price Target and Rating

Average Stock Price Target
$110.25
High Stock Price Target
$118.00
Low Stock Price Target
$102.00
Potential Upside/Downside
+31.7%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.70
Research Coverage
10 Analysts

Profitability

Trailing P/E Ratio
42.92
Forward P/E Ratio
21.03
P/E Growth
2.25
Net Income
$392.30 million
Pretax Margin
14.95%

Debt

Sales & Book Value

Annual Sales
$3.93 billion
Cash Flow
$5.27 per share
Price / Cash Flow
15.87
Book Value
$40.50 per share
Price / Book
2.07

Miscellaneous

Free Float
195,591,000
Market Cap
$16.74 billion
Optionable
Optionable
Beta
1.02

Social Links

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (NASDAQ:COO) was last updated on 3/26/2025 by MarketBeat.com Staff
From Our Partners